Pfenex And Alvogen Launch US Teriparatide

First Pfenex Launch Comes As Firm Waits For Equivalence Designation

Pfenex marketing partner Alvogen has introduced the firm’s Bonsity version of teriparatide in the US. Representing the first Pfenex-developed product to hit the market, the launch comes as the companies are still awaiting a formal equivalence designation from the FDA.

Debut
Pfenex is making its debut in the US with teriparatide • Source: Shutterstock

Pfenex and marketing partner Alvogen have launched the firm’s PF708 version of teriparatide in the US.

“We are pleased to announce the availability of teriparatide injection in pharmacies, the first new US Food and Drug Administration-approved...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Products

More from Generics Bulletin